Cerner Co. (CERN) Holdings Raised by Norinchukin Bank The

Norinchukin Bank The raised its position in Cerner Co. (NASDAQ:CERN) by 7.7% during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 25,249 shares of the company’s stock after purchasing an additional 1,804 shares during the period. Norinchukin Bank The’s holdings in Cerner were worth $1,702,000 as of its most recent filing with the Securities and Exchange Commission.

Other large investors have also recently made changes to their positions in the company. State of Wisconsin Investment Board increased its position in shares of Cerner by 16.8% in the 3rd quarter. State of Wisconsin Investment Board now owns 425,712 shares of the company’s stock valued at $30,362,000 after purchasing an additional 61,326 shares during the last quarter. Mitsubishi UFJ Kokusai Asset Management Co. Ltd. increased its position in shares of Cerner by 5.7% in the 3rd quarter. Mitsubishi UFJ Kokusai Asset Management Co. Ltd. now owns 45,080 shares of the company’s stock valued at $3,215,000 after purchasing an additional 2,426 shares during the last quarter. Advantus Capital Management Inc increased its position in shares of Cerner by 8.6% in the 3rd quarter. Advantus Capital Management Inc now owns 31,997 shares of the company’s stock valued at $2,282,000 after purchasing an additional 2,543 shares during the last quarter. Kalos Management Inc. increased its position in shares of Cerner by 32.9% in the 3rd quarter. Kalos Management Inc. now owns 13,155 shares of the company’s stock valued at $938,000 after purchasing an additional 3,254 shares during the last quarter. Finally, Capital International Investors boosted its holdings in shares of Cerner by 0.3% in the 3rd quarter. Capital International Investors now owns 4,851,296 shares of the company’s stock valued at $345,994,000 after buying an additional 12,178 shares in the last quarter. 81.63% of the stock is currently owned by institutional investors.

In related news, VP Michael R. Battaglioli sold 4,000 shares of the stock in a transaction on Wednesday, December 13th. The shares were sold at an average price of $69.89, for a total transaction of $279,560.00. Following the completion of the sale, the vice president now owns 4,000 shares in the company, valued at approximately $279,560. The sale was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, VP Jeffrey A. Townsend sold 230,000 shares of the stock in a transaction on Tuesday, February 13th. The stock was sold at an average price of $61.94, for a total transaction of $14,246,200.00. The disclosure for this sale can be found here. In the last quarter, insiders have sold 348,100 shares of company stock valued at $22,519,016. 13.11% of the stock is owned by company insiders.

CERN has been the subject of several research analyst reports. Zacks Investment Research cut shares of Cerner from a “buy” rating to a “hold” rating in a report on Thursday, January 4th. Evercore ISI initiated coverage on shares of Cerner in a report on Thursday, January 18th. They issued an “in-line” rating and a $77.00 target price for the company. BidaskClub cut shares of Cerner from a “hold” rating to a “sell” rating in a report on Wednesday, January 24th. Robert W. Baird upgraded shares of Cerner from a “neutral” rating to an “outperform” rating and upped their target price for the company from $67.00 to $76.00 in a report on Tuesday, October 31st. Finally, Royal Bank of Canada restated a “buy” rating and issued a $76.00 target price on shares of Cerner in a report on Wednesday, February 7th. One equities research analyst has rated the stock with a sell rating, twelve have given a hold rating and eight have assigned a buy rating to the stock. The company has an average rating of “Hold” and a consensus target price of $67.05.

Shares of Cerner Co. (CERN) opened at $64.53 on Friday. The firm has a market cap of $20,923.70, a price-to-earnings ratio of 25.11, a P/E/G ratio of 1.88 and a beta of 0.90. The company has a debt-to-equity ratio of 0.11, a quick ratio of 2.99 and a current ratio of 3.01. Cerner Co. has a 52 week low of $54.01 and a 52 week high of $73.86.

Cerner (NASDAQ:CERN) last issued its quarterly earnings results on Tuesday, February 6th. The company reported $0.58 earnings per share for the quarter, missing the Zacks’ consensus estimate of $0.61 by ($0.03). The business had revenue of $1.31 billion for the quarter, compared to analyst estimates of $1.33 billion. Cerner had a return on equity of 16.82% and a net margin of 16.86%. The firm’s revenue for the quarter was up 4.5% on a year-over-year basis. During the same quarter in the prior year, the company earned $0.61 EPS. analysts forecast that Cerner Co. will post 2.42 earnings per share for the current year.

ILLEGAL ACTIVITY WARNING: “Cerner Co. (CERN) Holdings Raised by Norinchukin Bank The” was originally posted by StockNewsTimes and is the sole property of of StockNewsTimes. If you are accessing this story on another domain, it was illegally copied and republished in violation of US & international copyright & trademark legislation. The legal version of this story can be accessed at https://stocknewstimes.com/2018/02/24/cerner-co-cern-holdings-raised-by-norinchukin-bank-the.html.

Cerner Company Profile

Cerner Corporation (Cerner) is a supplier of healthcare information technology (HCIT). The Company offers a range of intelligent solutions and services that support the clinical, financial and operational needs of organizations of all sizes. The Company’s segments include Domestic and Global. The Domestic segment includes revenue contributions and expenditures associated with business activity in the United States.

Want to see what other hedge funds are holding CERN? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cerner Co. (NASDAQ:CERN).

Institutional Ownership by Quarter for Cerner (NASDAQ:CERN)

Receive News & Ratings for Cerner Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cerner and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply